Does thalamotomy alter the course of Parkinson's disease?
Tasker
R R
RR
Division of Neurosurgery, Toronto Hospital, Canada.
DeCarvalho
G C
GC
Li
C S
CS
Kestle
J R
JR
D000328:Adult; D017668:Age of Onset; D000368:Aged; D000978:Antiparkinson Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D007839:Functional Laterality / Q000502:physiology; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009127:Muscle Rigidity / Q000209:etiology / Q000628:therapy; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy / Q000601:surgery*; D013788:Thalamus / Q000601:surgery*; D016896:Treatment Outcome; D014202:Tremor / Q000209:etiology / Q000628:therapy
D000978:Antiparkinson Agents; D007980:Levodopa